Aldebaran Capital, LLC Aclaris Therapeutics, Inc. Transaction History
Aldebaran Capital, LLC
- $105 Billion
- Q4 2024
A detailed history of Aldebaran Capital, LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Aldebaran Capital, LLC holds 1,016,958 shares of ACRS stock, worth $1.69 Million. This represents 2.4% of its overall portfolio holdings.
Number of Shares
1,016,958
Previous 1,043,152
2.51%
Holding current value
$1.69 Million
Previous $1.2 Billion
110.24%
% of portfolio
2.4%
Previous 1.1%
Shares
3 transactions
Others Institutions Holding ACRS
# of Institutions
106Shares Held
87.8MCall Options Held
293KPut Options Held
124K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$23.7 Million21.95% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$16 Million0.04% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$14.8 Million4.3% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD6.2MShares$10.3 Million0.61% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.67MShares$7.75 Million0.19% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $111M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...